Long-Term, Open-Label, Safety Study of Edivoxetine Monotherapy in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Emel Serap Monkul Nery(Eli Lilly (United States)), David Pérahia(École Normale Supérieure Paris-Saclay), Jonna Ahl(Eli Lilly (United States)), Peng Liu(Xidian University), Mark E. Bangs
Journal of Child and Adolescent Psychopharmacology
April 12, 2017
Cited by 4


Related Papers